Inactive Instrument

SOL S.p.A. Share Price CBOE EUROPE - CXE

Equities

0NJP

IT0001206769

Commodity Chemicals

End-of-day quote CBOE EUROPE - CXE
- EUR - Intraday chart for SOL S.p.A.

Financials

Sales 2024 * 1.59B 1.7B 134B Sales 2025 * 1.7B 1.83B 145B Capitalization 3B 3.22B 255B
Net income 2024 * 162M 174M 13.73B Net income 2025 * 173M 185M 14.67B EV / Sales 2024 * 2.18 x
Net Debt 2024 * 459M 492M 38.91B Net Debt 2025 * 485M 519M 41.12B EV / Sales 2025 * 2.05 x
P/E ratio 2024 *
18.6 x
P/E ratio 2025 *
17.3 x
Employees -
Yield 2024 *
1.36%
Yield 2025 *
1.45%
Free-Float 36.98%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 62 03/09/90
Chief Executive Officer 66 14/05/90
Investor Relations Contact - -
Members of the board TitleAgeSince
Chief Executive Officer 62 03/09/90
Director/Board Member 65 26/04/98
Director/Board Member 62 -
More insiders
SOL SpA is an Italy-based company primarily engaged in the research, production and distribution of industrial, pure and medicinal gases. It is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
More about the company